Health
FDA to allow Florida to import cheaper drugs from Canada
Florida has been granted approval by the US Food and Drug Administration (FDA) to import prescription drugs directly from Canada. It is the first state
India orders new drug manufacturing rules
Prime Minister Narendra Modi’s government, rocked by a series of deaths abroad linked to drugs made in India since 2022, ordered Indian pharmaceutical companies to
FDA ordered to reconsider denial of approval of vape products
A federal appeals court on Wednesday ordered the U.S. Food and Drug Administration to reconsider its decision barring two makers of flavoured e-cigarette liquid from
Canada has approved Pfizer’s gene therapy to treat blood clotting disorders
Pfizer said Canada’s health regulator has approved its gene therapy to treat a rare inherited blood clotting disorder called haemophilia B, even before the US
Brazilian city launches first mass vaccination against dengue fever
The city government said that the city of Dourados in the Brazilian state of Mato Grosso do Sul on Wednesday launched the country’s first mass
Record-breaking doctors’ strike puts pressure on England’s health system
Junior doctors in England on Wednesday began a six-day strike over pay, the longest strike in the 75-year history of the state-run National Health Service,
AstraZeneca and Sanofi RSV paediatric vaccinations approved in China
AstraZeneca said on Tuesday that its infant immunisation against respiratory syncytial virus, developed with the help of Sanofi, has received approval in China. The drugmakers
Moderna moves to modernise Oppenheimer and sets sales growth target for 2025
Moderna shares rose nearly 14% on Tuesday as brokerage Oppenheimer upgraded the stock to “outperform” and the vaccine maker’s CEO reiterated the company’s goal of
AstraZeneca and Sanofi RSV paediatric vaccinations approved in China
AstraZeneca said Tuesday that its infant immunisation against respiratory syncytial virus, developed with the help of Sanofi, has won approval in China. The drugmakers have
Novartis signs gene therapy deal with Voyager
Voyager Therapeutics said Novartis would pay $100 million upfront as part of a licensing agreement to develop gene therapy candidates. Voyager would provide Novartis with